Basel, Switzerland

Michael Kammerer

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Michael Kammerer: Innovator in Pharmaceutical Chemistry

Introduction

Michael Kammerer is an accomplished inventor based in Basel, Switzerland, with a significant contribution to the field of pharmaceutical chemistry. He holds a total of five patents, focusing on advancements in drug formulations and production processes that enhance the efficacy and stability of pharmaceutical compounds.

Latest Patents

Among his latest patents are innovative products related to diazabicyclooctane derivatives. One notable invention is the "Crystalline forms of diazabicyclooctane derivatives and production process thereof," which outlines the crystalline forms of a specific compound and methods for their production and application. Additionally, he has developed "Pharmaceutical forms of diazabicyclooctane derivatives and manufacturing method thereof," which details processes for producing both crystalline and amorphous forms of these derivatives.

Career Highlights

Michael has made significant strides in his career by working with esteemed companies in the pharmaceutical industry. He has been associated with Hoffmann-La Roche Inc., a global leader in pharmaceuticals, and Fedora Pharmaceuticals Inc., where he applied his expertise in drug development and formulation.

Collaborations

Throughout his career, Michael Kammerer has collaborated with notable professionals in his field. His coworkers, Urs Schwitter and Pascal Dott, have contributed to various projects, enhancing the quality and reach of their innovations in pharmaceutical sciences.

Conclusion

Michael Kammerer stands out as a prominent inventor whose work has had a considerable impact on the pharmaceutical industry. His patents not only demonstrate his innovative spirit but also improve the therapeutic options available to patients. As he continues to develop new inventions, the medical community eagerly anticipates the advancements that will emerge from his research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…